secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2022-04-14T23:59:59+00:00
Accession:  0001193125-22-105541
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two IO Biotech directors to step down at 2022 annual meeting
------------------------------------------------------------

- Dr. Claus Andersson and Dr. Emmanuelle Coutanceau notified the Board they will not stand for reelection.
- Effective at the Company's 2022 annual meeting of stockholders.
- Decisions are not due to any disagreement with the Company or Board regarding operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/0001193125-22-105541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312522105541/d299788d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-105541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer